+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mesenchymal stem cells as therapeutic agents and in gene delivery for the treatment of glioma; ;



Mesenchymal stem cells as therapeutic agents and in gene delivery for the treatment of glioma; ;



Journal of Zhejiang University Science B 18(9): 737-746




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065017854

Download citation: RISBibTeXText

DOI: 10.1631/jzus.b1600337


Related references

Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases. Journal of Controlled Release 162(2): 464-473, 2012

Sc-24 * Improvement Of Human Mesenchymal Stem Cell Homing In Delivery Of Therapeutic Agents To Glioma Stem Cell Xenografts. Neuro-Oncology 16(Suppl 5): v202, 2014

Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma. Cancer Gene Therapy 19(8): 572-578, 2012

Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents. Current Medicinal Chemistry 23(5): 455-463, 2016

Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells. Genomics Data 5: 333-336, 2015

Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. Drug Design Development and Therapy 9: 969-976, 2015

Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis. Analytical Cellular Pathology 2017: 7492836, 2017

Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment. Frontiers in Pharmacology 9: 259, 2018

Investigation of the potential of human mesenchymal stem cells (hMSC) as vectors for therapeutic gene delivery to breast tumours. 2007

VEGF therapeutic gene delivery using dendrimer type bio-reducible polymer into human mesenchymal stem cells (hMSCs). Journal of Controlled Release 220(Pt A): 222-228, 2015

The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review. Frontiers in Immunology 9: 2056, 2018

Use of human mesenchymal stem cells as gene delivery vehicles for the treatment of Fabrys disease. Blood 96(11 Part 1): 845a, 2000

Genetically-manipulated adult stem cells as therapeutic agents and gene delivery vehicle for wound repair and regeneration. Journal of Controlled Release 157(3): 321-330, 2012

Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget 4(2): 346-361, 2013

Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL. Stem Cell Research and Therapy 7(1): 149, 2016